AusDiagnostics

Executive Summary

AusDiagnostics is an Australian-based diagnostics company that has developed a proprietary multiplexed real-time PCR (MT-PCR) platform, enabling simultaneous detection of multiple pathogens in a single test. The company offers a broad portfolio of panels covering human infectious diseases (e.g., respiratory, gastrointestinal, and sexually transmitted infections), animal health, and applied testing (e.g., food safety, AMR, and genotyping). Founded in 2006 and employing 200–500 staff, AusDiagnostics has achieved commercial stage with a strong presence in Australian and New Zealand laboratories and is expanding globally. Its MT-PCR technology provides high sensitivity, rapid turnaround times, and cost efficiency, positioning it as a key player in the syndromic testing market. While the company is privately held and financial details are limited, its established product lineup and growing adoption suggest a stable revenue base and potential for international growth.

Upcoming Catalysts (preview)

• Q3 2026Launch of new respiratory multiplex panel targeting emerging pathogens70% success
• H2 2026Strategic partnership or distribution agreement for entry into the US or European market50% success
• Q1 2027Regulatory approval (TGA or CE-IVDR) for expanded panel menu in applied testing80% success